4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="Par1">This study aimed to identify predictors of adverse psychological experiences among direct-to-consumer (DTC) genomic test consumers. We performed a secondary analysis on data from the Scripps Genomic Health Initiative (SGHI), which studied 2037 individuals tested with commercially available tests yielding personalized risk estimates for 23 common, genetically complex diseases. As part of the original study, the participants completed baseline and follow-up survey measures assessing demographics, personal and family health history, attitudes toward genetic testing, anxiety (State-Trait Anxiety Inventory (STAI)), test-related distress (Impact of Event Scale—Revised (IES-R)), and reactions to receipt of results. To further describe the participants who had an adverse psychological outcome, this secondary analysis defined two different variables (“distress response” and “psychologically sensitive participants”) and examined their relationship to various demographic variables and other survey responses. One hundred thirty participants (6.4%) were defined as having a “distress response” to receipt of results based on changes in STAI and/or IES. Four hundred thirty-one participants (21.2%) were defined as being “psychologically sensitive” based on high STAI scores both pre- and post-receipt of results. For psychologically sensitive subjects, younger age emerged as a predictor ( <i>p</i> &lt; 0.0005). Family history and personal history were only significant predictors for Alzheimer’s disease in the psychologically sensitive participants ( <i>p</i> = .03) and restless leg syndrome in those with a distress response ( <i>p</i> = .03). Psychologically sensitive participants were more likely to indicate a number of pre-test concerns than were controls, but neither group of participants were any more likely to follow up with their physician or a free genetic counseling service after the return of results. </p>

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          An agenda for personalized medicine.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing.

              Direct-to-consumer genetic testing has generated speculation about how customers will interpret results and how these interpretations will influence healthcare use and behavior; however, few empirical data on these topics exist. We conducted an online survey of DTC customers of 23andMe, deCODEme, and Navigenics to begin to address these questions. Random samples of U.S. DTC customers were invited to participate. Survey topics included demographics, perceptions of two sample DTC results, and health behaviors following DTC testing. Of 3,167 DTC customers invited, 33% (n = 1,048) completed the survey. Forty-three percent of respondents had sought additional information about a health condition tested; 28% had discussed their results with a healthcare professional; and 9% had followed up with additional lab tests. Sixteen percent of respondents had changed a medication or supplement regimen, and one-third said they were being more careful about their diet. Many of these health-related behaviors were significantly associated with responses to a question that asked how participants would perceive their colon cancer risk (as low, moderate, or high) if they received a test result showing an 11% lifetime risk, as compared to 5% risk in the general population. Respondents who would consider themselves to be at high risk for colon cancer were significantly more likely to have sought information about a disease (p = 0.03), discussed results with a physician (p = 0.05), changed their diet (p = 0.02), and started exercising more (p = 0.01). Participants' personal health contexts--including personal and family history of disease and quality of self-perceived health--were also associated with health-related behaviors after testing. Subjective interpretations of genetic risk data and personal context appear to be related to health behaviors among DTC customers. Sharing DTC test results with healthcare professionals may add perceived utility to the tests.
                Bookmark

                Author and article information

                Journal
                Journal of Community Genetics
                J Community Genet
                Springer Nature
                1868-310X
                1868-6001
                July 2018
                November 13 2017
                July 2018
                : 9
                : 3
                : 217-225
                Article
                10.1007/s12687-017-0339-z
                6002310
                29130150
                0fda1bcd-1f04-48eb-a7af-058aca7f5c74
                © 2018

                http://www.springer.com/tdm

                History

                Comments

                Comment on this article